| Financial Year |
March 31 2023 |
| Monetary Funds |
4,930,695,161.65 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,853,949,295.92 |
| Advances to Suppliers |
960,187,866.98 |
| Other Receivables |
71,784,054.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
440,757,978.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
542,549,108.59 |
| Total Current Assets |
8,914,051,117.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,032,470,534.41 |
| Investment Properties |
169,046,877.38 |
| Fixed Assetes |
19,791,571,724.50 |
| Under-construction Projects |
839,051,547.93 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
783,030,080.10 |
| R&D expenses |
-- |
| Goodwill |
4,129,646.33 |
| Long-Term Deferred and Prepaid Expenses |
740,539.42 |
| Deferred Income Tax Assets |
68,858,259.81 |
| Other Non-Current Assets |
187,223,173.65 |
| Sub-Total of Non-Current Assets |
22,948,386,201.12 |
| Total Assets |
31,862,437,318.32 |
| Short-Term Loans |
5,925,157,660.54 |
| Trading Financial liabilities |
-- |
| Notes Payable |
897,705,078.48 |
| Accounts Payable |
504,378,660.63 |
| Accounts Received In Advance |
294,293.89 |
| Employee Compensation Payable |
128,654,454.60 |
| Taxes Payable |
147,664,334.13 |
| Interest Payable |
-- |
| Dividend Payable |
11,352,054.78 |
| Other payables |
1,244,306,647.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,056,071,201.22 |
| Other Current Liabilities |
86,405,180.63 |
| Sub-Total of Current Liabilities |
13,994,747,738.83 |
| Long-term Loans |
12,798,436,512.79 |
| Bonds Payable |
499,742,701.37 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,199,390.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
13,641,993,413.49 |
| Total Liabilities |
27,636,741,152.32 |
| Paid-In Capital(Or Share Stock) |
1,377,994,126.00 |
| Capital Surplus |
1,406,517,607.80 |
| Surplus Reserve |
67,952,066.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
848,951,441.27 |
| Minority Stockholder's Interest |
456,110,652.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,769,585,513.56 |
| Owner's Equity（Stockholder's Equity） |
4,225,696,166.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
31,862,437,318.32 |
